NEUPHORIA THERAPEUTICS INC (NEUP) Stock Analyst Ratings
USA - NASDAQ:NEUP - US64136E1029 - Common Stock
4.55 USD
+0.15 (+3.41%)
4.51 USD
-0.04 (-0.88%)
ChartMill assigns a Buy % Consensus number of 82% to NEUP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.82. This target is 335.65% above the current price.
NEUP was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NEUP.
In the previous month the buy percentage consensus was at a similar level.
NEUP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
NEUPHORIA THERAPEUTICS INC / NEUP FAQ
What is the price target for NEUP stock?
9 analysts have analysed NEUP and the average price target is 19.82 USD. This implies a price increase of 335.65% is expected in the next year compared to the current price of 4.55.
Can you provide the consensus rating for NEUPHORIA THERAPEUTICS INC stock?
The consensus rating for NEUPHORIA THERAPEUTICS INC (NEUP) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NEUPHORIA THERAPEUTICS INC (NEUP) stock?
The number of analysts covering NEUPHORIA THERAPEUTICS INC (NEUP) is 9.